Sex Steroids and Brain Outcome from Cardiac Arrest/Cardiopulmonary Resuscitation
性类固醇和心脏骤停/心肺复苏的脑结果
基本信息
- 批准号:7529169
- 负责人:
- 金额:$ 13.61万
- 依托单位:
- 依托单位国家:美国
- 项目类别:
- 财政年份:2002
- 资助国家:美国
- 起止时间:2002-09-30 至 2012-01-31
- 项目状态:已结题
- 来源:
- 关键词:AgeAndrogen ReceptorAndrogensAnimalsBrainBrain InjuriesCARTPT geneCandidate Disease GeneCardiacCardiopulmonary ArrestCardiopulmonary ResuscitationCardiovascular DiseasesCastrationCerebral IschemiaCerebrumCessation of lifeChronicClinicalConditionCoronary heart diseaseDataEstradiolEstrogen Receptor betaEstrogen ReceptorsEstrogensEvaluationEventFemaleFundingGenetic TranscriptionGonadal Steroid HormonesHeart ArrestHormonesHumanIndividualInjuryIschemiaIschemic Neuronal InjuryKnock-outLifeLinkMammalsMediatingMusNeurologicNeurological outcomeNeuronal InjuryNeuronsNeuropeptidesNeuroprotective AgentsNeuropsychologyOutcomePathway interactionsPatientsPhosphotransferasesPlayProcessProgesteroneProto-OncogenesPurposeRecovery of FunctionRelative (related person)ResearchRiskRoleSex CharacteristicsSignal TransductionSourceSteroidsStrokeTechniquesTestingTestosteroneTransgenic MiceWild Type MouseWomanbrain shapebrain tissuecell injurycomparativeextracellularmalemenneuroprotectionneuropsychologicalnovelpreventreceptorsexsudden cardiac death
项目摘要
DESCRIPTION (provided by applicant): Despite five decades of research concerning cardiac arrest/cardiopulmonary resuscitation (CA/CPR), clinical outcome remains poor. Only 5% of individuals who suffer CA are successfully resuscitated to the extent that they return to normal, productive lives, and neuropsychological deficiencies remain prevalent in the remaining 95% of patients. One reason why outcome from CA/CPR remains poor is that mechanisms of cell injury and targets for neuroprotection have been poorly elucidated. Women are at lower risk than men for cardiovascular disease yet cerebral ischemic events occur in both sexes. The role of estrogens in humans is controversial; however, we demonstrated in the past funding period that female mice have better outcome than males after CA/CPR. We now focus on potential transcriptional mechanisms by which estradiol exerts its neuroprotective action in CA/CPR. Using a microarray technique, we identified gene candidates that are induced/suppressed by estrogen under ischemic conditions. One provocative candidate, the neuropeptide cocaine and amphetamine regulated transcript (CART) is strongly induced by cerebral ischemia and provides robust neuroprotection. We propose to determine if CART is an important mechanism by which estradiol reduces neuronal injury after CA/CPR and whether CART exerts its neuroprotective effects via the extracellular regulated kinase (ERK) pathway. While most research has focused on understanding the role of estradiol in ischemia, the role of androgens in ischemic sensitivity is unknown. We propose to study testosterone, a sex steroid with potential to exacerbate brain injury from CA/CPR. Our preliminary data suggests that testosterone increases and castration decreases neuronal injury after CA/CPR, and we hypothesize that androgens signal through their cognate receptor to orchestrate neuronal ischemic death. Thus, this proposal will focus on novel mechanisms by which male and female sex steroids shape brain outcome after CA/CPR. Aim 1 determines if estradiol enhances CART expression and suppresses ERK activation after CA/CPR in a region-specific manner. Aim 2 determines if CART protection requires signaling via estrogen receptor beta. Aim 3 determines if androgens play an important role in neuropathological and functional recovery after CA/CPR. Finally, Aim 4 determines if the androgen receptor is essential to how androgen enhances post arrest brain injury.
描述(由申请人提供):尽管对心脏骤停/心肺复苏(CA/CPR)进行了50年的研究,但临床结局仍然很差。只有5%的CA患者成功复苏,恢复正常的生活,其余95%的患者仍然普遍存在神经心理缺陷。CA/CPR结果仍然不佳的一个原因是细胞损伤机制和神经保护靶点尚未得到很好的阐明。女性患心血管疾病的风险低于男性,但脑缺血事件在两性中都有发生。雌激素在人类中的作用是有争议的;然而,我们在过去的资助期间证明,CA/CPR后雌性小鼠的结果比雄性小鼠好。我们现在关注的是雌二醇在CA/CPR中发挥神经保护作用的潜在转录机制。使用微阵列技术,我们确定了在缺血条件下雌激素诱导/抑制的候选基因。一个挑衅性的候选者,神经肽可卡因和安非他明调节的转录物(CART)是由脑缺血强烈诱导,并提供强大的神经保护。我们建议确定CART是否是雌二醇减少CA/CPR后神经元损伤的重要机制,以及CART是否通过细胞外调节激酶(ERK)途径发挥其神经保护作用。虽然大多数研究集中在了解雌二醇在缺血中的作用,但雄激素在缺血敏感性中的作用尚不清楚。我们建议研究睾酮,一种有可能加剧CA/CPR脑损伤的性类固醇。我们的初步数据表明,睾丸激素增加和去势减少CA/CPR后神经元损伤,我们假设雄激素信号通过其同源受体协调神经元缺血性死亡。因此,这项建议将集中在新的机制,男性和女性性类固醇形状CA/CPR后的大脑结果。目的1确定雌二醇是否以区域特异性方式增强CA/CPR后CART表达并抑制ERK激活。目的2确定CART保护是否需要通过雌激素受体β信号传导。目的3确定雄激素是否在CA/CPR后的神经病理和功能恢复中起重要作用。最后,目的4确定雄激素受体是否对雄激素如何增强停搏后脑损伤至关重要。
项目成果
期刊论文数量(0)
专著数量(0)
科研奖励数量(0)
会议论文数量(0)
专利数量(0)
数据更新时间:{{ journalArticles.updateTime }}
{{
item.title }}
{{ item.translation_title }}
- DOI:
{{ item.doi }} - 发表时间:
{{ item.publish_year }} - 期刊:
- 影响因子:{{ item.factor }}
- 作者:
{{ item.authors }} - 通讯作者:
{{ item.author }}
数据更新时间:{{ journalArticles.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ monograph.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ sciAawards.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ conferencePapers.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ patent.updateTime }}
RICHARD J TRAYSTMAN其他文献
RICHARD J TRAYSTMAN的其他文献
{{
item.title }}
{{ item.translation_title }}
- DOI:
{{ item.doi }} - 发表时间:
{{ item.publish_year }} - 期刊:
- 影响因子:{{ item.factor }}
- 作者:
{{ item.authors }} - 通讯作者:
{{ item.author }}
{{ truncateString('RICHARD J TRAYSTMAN', 18)}}的其他基金
Sex Steroids and Brain Outcome from Cardiac Arrest/Cardiopulmonary Resuscitation
性类固醇和心脏骤停/心肺复苏的脑结果
- 批准号:
7755865 - 财政年份:2002
- 资助金额:
$ 13.61万 - 项目类别:
Sex differences in brain injury following pediatric cardiac arrest
小儿心脏骤停后脑损伤的性别差异
- 批准号:
8694751 - 财政年份:2002
- 资助金额:
$ 13.61万 - 项目类别:
相似海外基金
Androgen receptor: A master regulator of lipid metabolism
雄激素受体:脂质代谢的主要调节因子
- 批准号:
DP230103210 - 财政年份:2023
- 资助金额:
$ 13.61万 - 项目类别:
Discovery Projects
Regulation of androgen receptor signaling in prostate cancer by protein arginine methylation
通过蛋白质精氨酸甲基化调节前列腺癌中的雄激素受体信号传导
- 批准号:
10584689 - 财政年份:2023
- 资助金额:
$ 13.61万 - 项目类别:
Structural and functional analysis of a novel class of androgen receptor antagonists
一类新型雄激素受体拮抗剂的结构和功能分析
- 批准号:
10650956 - 财政年份:2023
- 资助金额:
$ 13.61万 - 项目类别:
Role of the Androgen Receptor in Insulin Secretion in the Male
雄激素受体在男性胰岛素分泌中的作用
- 批准号:
10488954 - 财政年份:2023
- 资助金额:
$ 13.61万 - 项目类别:
Targeting tumor cell macrophage lipid interactions to overcome resistance to androgen receptor targeted therapy
靶向肿瘤细胞巨噬细胞脂质相互作用以克服对雄激素受体靶向治疗的耐药性
- 批准号:
10651105 - 财政年份:2023
- 资助金额:
$ 13.61万 - 项目类别:
Preclinical development of ONCT-505, an Androgen Receptor Antagonist and Degrader, as new potential therapeutic for Kennedy's Disease
ONCT-505(一种雄激素受体拮抗剂和降解剂)的临床前开发,作为肯尼迪病的新潜在治疗方法
- 批准号:
10603636 - 财政年份:2023
- 资助金额:
$ 13.61万 - 项目类别:
Proliferating cell nuclear antigen in regulation of androgen receptor signalings in castration-resistant prostate cancer cells
增殖细胞核抗原对去势抵抗性前列腺癌细胞雄激素受体信号传导的调节
- 批准号:
10544062 - 财政年份:2022
- 资助金额:
$ 13.61万 - 项目类别:
Effects of androgen receptor (AR) signaling on CD4+ T cell metabolism during airway inflammation
气道炎症期间雄激素受体 (AR) 信号对 CD4 T 细胞代谢的影响
- 批准号:
10534943 - 财政年份:2022
- 资助金额:
$ 13.61万 - 项目类别:
TITLE: BLADDER CANCER CHEMOPREVENTION USING THE ANDROGEN RECEPTOR INHIBITOR APALUTAMIDE
标题:使用雄激素受体抑制剂阿帕鲁胺进行膀胱癌化学预防
- 批准号:
10677989 - 财政年份:2022
- 资助金额:
$ 13.61万 - 项目类别: